DE69708109D1 - Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben - Google Patents

Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben

Info

Publication number
DE69708109D1
DE69708109D1 DE69708109T DE69708109T DE69708109D1 DE 69708109 D1 DE69708109 D1 DE 69708109D1 DE 69708109 T DE69708109 T DE 69708109T DE 69708109 T DE69708109 T DE 69708109T DE 69708109 D1 DE69708109 D1 DE 69708109D1
Authority
DE
Germany
Prior art keywords
beta
creatine
alanine
tissue
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69708109T
Other languages
English (en)
Other versions
DE69708109T2 (de
Inventor
Mark Dunnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9616910.7A external-priority patent/GB9616910D0/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69708109D1 publication Critical patent/DE69708109D1/de
Publication of DE69708109T2 publication Critical patent/DE69708109T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Husbandry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69708109T 1996-08-12 1997-08-12 Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben Expired - Lifetime DE69708109T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9616910.7A GB9616910D0 (en) 1996-08-12 1996-08-12 A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals
GBGB9621914.2A GB9621914D0 (en) 1996-08-12 1996-10-21 A method to simultaneously increase ›-alanylhistidine dipeptides and creatine in bodily tissues of humans and animals
PCT/IB1997/001117 WO1998006278A1 (en) 1996-08-12 1997-08-12 Methods and compositions for increasing the anaerobic working capacity in tissues

Publications (2)

Publication Number Publication Date
DE69708109D1 true DE69708109D1 (de) 2001-12-13
DE69708109T2 DE69708109T2 (de) 2002-08-01

Family

ID=26309862

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69708109T Expired - Lifetime DE69708109T2 (de) 1996-08-12 1997-08-12 Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben

Country Status (9)

Country Link
EP (1) EP0918469B1 (de)
JP (1) JP4439019B2 (de)
CN (1) CN1268234C (de)
AT (1) ATE208144T1 (de)
AU (1) AU4029397A (de)
CA (1) CA2263184C (de)
DE (1) DE69708109T2 (de)
DK (1) DK0918469T3 (de)
WO (1) WO1998006278A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
JPH11322617A (ja) * 1998-05-07 1999-11-24 Tokiwa Yakuhin Kogyo Kk チキンまたはカキ抽出物を含有する胃潰瘍予防用または治療用の医薬組成物
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US6855727B2 (en) 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
JP4873778B2 (ja) * 2000-12-04 2012-02-08 焼津水産化学工業株式会社 抗疲労剤
JP2010150263A (ja) * 2003-04-10 2010-07-08 Natural Alternatives Internatl 組織における無酸素性作業能力を高めるための方法及び組成物
KR101275660B1 (ko) * 2005-05-23 2013-06-17 내츄럴 얼터너티브즈 인터내셔날, 인크. 베타-알라닌의 지속적 방출을 위한 조성물 및 방법
CN105963299B (zh) * 2016-04-25 2018-09-18 南京农业大学 一种渔用糖代谢调控物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54159393A (en) * 1978-06-08 1979-12-17 Ajinomoto Co Inc Polyamino acid-coated activated carbon
JPS6016934A (ja) * 1983-07-06 1985-01-28 Kaneshiro Nagai 抗腫瘍剤
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
JPH0395125A (ja) * 1989-05-23 1991-04-19 Otsuka Pharmaceut Co Ltd カルシウム代謝改善剤
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
JP2873493B2 (ja) * 1990-08-09 1999-03-24 理化学研究所 血糖調節剤
JP2873497B2 (ja) * 1990-09-03 1999-03-24 理化学研究所 脂質代謝調節剤
JPH0624976A (ja) * 1992-07-10 1994-02-01 Rikagaku Kenkyusho 輸液用組成物

Also Published As

Publication number Publication date
ATE208144T1 (de) 2001-11-15
CN1268234C (zh) 2006-08-09
DE69708109T2 (de) 2002-08-01
AU4029397A (en) 1998-03-06
JP4439019B2 (ja) 2010-03-24
CA2263184C (en) 2008-06-03
EP0918469A1 (de) 1999-06-02
CA2263184A1 (en) 1998-02-19
JP2000516464A (ja) 2000-12-12
CN1237881A (zh) 1999-12-08
WO1998006278A1 (en) 1998-02-19
DK0918469T3 (da) 2003-02-10
EP0918469B1 (de) 2001-11-07

Similar Documents

Publication Publication Date Title
EA200001154A1 (ru) Твердые композиции, содержащие производные гамма-аминомасляной кислоты, и способ их получения
ATE330468T1 (de) Lösung zur evaluierung und konservierung
EA200100957A1 (ru) Композиция на основе аскорбиновой кислоты и способ лечения стареющей или поврежденной кожи
ATE243702T1 (de) Verfahren zur herstellung von ascorbinsäurederivaten
WO2003061768A3 (fr) Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaircir la peau
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
PT902789E (pt) Derivados de androsteno
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69708109D1 (de) Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben
EA200100791A1 (ru) Ингибиторы аминотрансфераз, зависимых от аминокислот с разветвленной цепью, и их применение в лечении диабетической ретинопатии
AU2003291134A1 (en) Use of diamide derivatives for inhibiting chronic tissue transplant rejection
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
WO2003055559A8 (de) Gegen bakterien, mycota und viren wirksame wirkstoffkombinationen auf der basis von dialkylsubstituierten essigsäuren und glycerinalkylethern
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69714056T2 (de) Cytostatische hydroxamsäurederivate
ATE194912T1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten
WO2000033852B1 (en) Compound and method for degrading amino acids
ATE245980T1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
BR0308633A (pt) Composições, métodos para bioestimular as agrìcolas, e, uso das composições
DK1673057T3 (da) Hårvækstinhibering
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DE69517247D1 (de) Phosphorylierte Derivate von Verbindungen mit antiinflammatorischen oder analgetischer Wirkung
RU95103161A (ru) Способ лечения хронической гепатитов